Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takahiro Ebata

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Biomed Research International|January 13, 2017
Functions of the Tumor Suppressors p53 and Rb in Actin Cytoskeleton RemodelingTakahiro Ebata, Hiroaki Hirata, Keiko Kawauchi
The Lancet. Oncology|February 13, 2016
Prophylactic dexamethasone for radiation-induced bone-pain flareTsukasa Ishiwata, Shunichiro Iwasawa, Ryota Kurimoto, et al.
Oncology Letters|July 12, 2017
Pirfenidone may revert the epithelial-to-mesenchymal transition in human lung adenocarcinomaRyota Kurimoto, Takahiro Ebata, Shunichiro Iwasawa, et al.
Oncology Reports|January 13, 2018
Inhibition of Gli leads to antitumor growth and enhancement of cisplatin-induced cytotoxicity in large cell neuroendocrine carcinoma of the lungTsukasa Ishiwata, Shunichiro Iwasawa, Takahiro Ebata, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 6, 2021
Risk factors for skeletal-related events in non-small cell lung cancer patients treated with bone-modifying agentsGo Saito, Takahiro Ebata, Tsukasa Ishiwata, et al.
Cellular and Molecular Life Sciences : CMLS|July 25, 2015
p53 regulates cytoskeleton remodeling to suppress tumor progressionKeigo Araki, Takahiro Ebata, Alvin Kunyao Guo, et al.
Cell Adhesion & Migration|July 8, 2017
Substrate rigidity-dependent positive feedback regulation between YAP and ROCK2Wataru Sugimoto, Katsuhiko Itoh, Yasumasa Mitsui, et al.
International Journal of Clinical Oncology|April 18, 2019
Feasibility of initial treatment in elderly patients with ovarian cancer in Japan: a retrospective studySeiko Bun, Mayu Yunokawa, Takahiro Ebata, et al.
Oncology|May 19, 2017
Amrubicin Monotherapy for Patients with Platinum-Pretreated Non-Gastrointestinal Non-Pancreatic Extrapulmonary Neuroendocrine CarcinomaTakahiro Ebata, Tatsunori Shimoi, Tsukasa Ishiwata, et al.
Internal Medicine (Tokyo, Japan)|March 3, 2017
Potential Activity of Amrubicin as a Salvage Therapy for Merkel Cell CarcinomaEmiko Sakaida, Takahiro Ebata, Shunichiro Iwasawa, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Biomed Research International|January 13, 2017
Functions of the Tumor Suppressors p53 and Rb in Actin Cytoskeleton RemodelingTakahiro Ebata, Hiroaki Hirata, Keiko Kawauchi
The Lancet. Oncology|February 13, 2016
Prophylactic dexamethasone for radiation-induced bone-pain flareTsukasa Ishiwata, Shunichiro Iwasawa, Ryota Kurimoto, et al.
Oncology Letters|July 12, 2017
Pirfenidone may revert the epithelial-to-mesenchymal transition in human lung adenocarcinomaRyota Kurimoto, Takahiro Ebata, Shunichiro Iwasawa, et al.
Oncology Reports|January 13, 2018
Inhibition of Gli leads to antitumor growth and enhancement of cisplatin-induced cytotoxicity in large cell neuroendocrine carcinoma of the lungTsukasa Ishiwata, Shunichiro Iwasawa, Takahiro Ebata, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 6, 2021
Risk factors for skeletal-related events in non-small cell lung cancer patients treated with bone-modifying agentsGo Saito, Takahiro Ebata, Tsukasa Ishiwata, et al.
Cellular and Molecular Life Sciences : CMLS|July 25, 2015
p53 regulates cytoskeleton remodeling to suppress tumor progressionKeigo Araki, Takahiro Ebata, Alvin Kunyao Guo, et al.
Cell Adhesion & Migration|July 8, 2017
Substrate rigidity-dependent positive feedback regulation between YAP and ROCK2Wataru Sugimoto, Katsuhiko Itoh, Yasumasa Mitsui, et al.
International Journal of Clinical Oncology|April 18, 2019
Feasibility of initial treatment in elderly patients with ovarian cancer in Japan: a retrospective studySeiko Bun, Mayu Yunokawa, Takahiro Ebata, et al.
Oncology|May 19, 2017
Amrubicin Monotherapy for Patients with Platinum-Pretreated Non-Gastrointestinal Non-Pancreatic Extrapulmonary Neuroendocrine CarcinomaTakahiro Ebata, Tatsunori Shimoi, Tsukasa Ishiwata, et al.
Internal Medicine (Tokyo, Japan)|March 3, 2017
Potential Activity of Amrubicin as a Salvage Therapy for Merkel Cell CarcinomaEmiko Sakaida, Takahiro Ebata, Shunichiro Iwasawa, et al.
Pageof 3